CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II) [NA]
Summary
Clinical trial PROMPT AF II compares PVI alone versus PVI with linear ablation for persistent atrial fibrillation; the study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: RECRUITING